Literature DB >> 28278386

Structural evaluations of tau protein conformation: methodologies and approaches.

Nicole L Zabik1,1, Matthew M Imhof1,1, Sanela Martic-Milne1,1.   

Abstract

Protein-misfolding diseases are based on a common principle of aggregation initiated by intra- and inter-molecular contacts. The structural and conformational changes induced by biochemical transformations such as post-translational modifications (PTMs), often lead to protein unfolding and misfolding. Thus, these order-to-disorder or disorder-to-order transitions may regulate cellular function. Tau, a neuronal protein, regulates microtubule (MT) structure and overall cellular integrity. However, misfolded tau modified by PTMs results in MT destabilization, toxic tau aggregate formation, and ultimately cell death, leading to neurodegeneration. Currently, the lack of structural information surrounding tau severely limits understanding of neurodegeneration. This minireview focuses on the current methodologies and approaches aimed at probing tau conformation and the role of conformation in various aspects of tau biochemistry. The recent applications of nuclear magnetic resonance, mass spectrometry, Förster resonance electron transfer, and molecular dynamics simulations toward structural analysis of conformational landscapes of tau will be described. The strategies developed for structural evaluation of tau may significantly improve our understanding of misfolding diseases.

Entities:  

Keywords:  FRET; MS; NMR; RMN; SP; dynamique moléculaire; hyper-phosphorylation; hyperphosphorylation; intrinsically disordered proteins; molecular dynamics; protéine tau; protéines intrinsèquement désordonnées; tau protein

Mesh:

Substances:

Year:  2017        PMID: 28278386      PMCID: PMC6145104          DOI: 10.1139/bcb-2016-0227

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  64 in total

Review 1.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.

Authors:  Benjamin Combs; Kellen Voss; T Chris Gamblin
Journal:  Biochemistry       Date:  2011-10-17       Impact factor: 3.162

3.  Mapping the potential energy landscape of intrinsically disordered proteins at amino acid resolution.

Authors:  Valéry Ozenne; Robert Schneider; Mingxi Yao; Jie-rong Huang; Loïc Salmon; Markus Zweckstetter; Malene Ringkjøbing Jensen; Martin Blackledge
Journal:  J Am Chem Soc       Date:  2012-08-28       Impact factor: 15.419

4.  Self-assembly of a beta-sheet protein governed by relief of electrostatic repulsion relative to van der Waals attraction.

Authors:  M R Caplan; P N Moore; S Zhang; R D Kamm; D A Lauffenburger
Journal:  Biomacromolecules       Date:  2000       Impact factor: 6.988

5.  Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.

Authors:  Summer L Bernstein; Nicholas F Dupuis; Noel D Lazo; Thomas Wyttenbach; Margaret M Condron; Gal Bitan; David B Teplow; Joan-Emma Shea; Brandon T Ruotolo; Carol V Robinson; Michael T Bowers
Journal:  Nat Chem       Date:  2009-07       Impact factor: 24.427

6.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

7.  Folding upon phosphorylation: translational regulation by a disorder-to-order transition.

Authors:  Lauren Ann Metskas; Elizabeth Rhoades
Journal:  Trends Biochem Sci       Date:  2015-03-10       Impact factor: 13.807

8.  NMR analysis of a Tau phosphorylation pattern.

Authors:  Isabelle Landrieu; Ludovic Lacosse; Arnaud Leroy; Jean-Michel Wieruszeski; Xavier Trivelli; Alain Sillen; Nathalie Sibille; Harald Schwalbe; Krishna Saxena; Thomas Langer; Guy Lippens
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

Review 9.  Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators.

Authors:  Vladimir N Uversky
Journal:  Front Mol Biosci       Date:  2014-07-25

10.  Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble.

Authors:  Shaolong Zhu; Agnesa Shala; Alexandr Bezginov; Adnan Sljoka; Gerald Audette; Derek J Wilson
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

View more
  6 in total

Review 1.  The propagation mechanisms of extracellular tau in Alzheimer's disease.

Authors:  Yun Wei; Meixia Liu; Dongxin Wang
Journal:  J Neurol       Date:  2021-04-28       Impact factor: 4.849

Review 2.  Advances and considerations in AD tau-targeted immunotherapy.

Authors:  Alice Bittar; Nemil Bhatt; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2019-12-10       Impact factor: 5.996

3.  Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer's disease.

Authors:  Yimin Mao; Daniel W Fisher; Shuxing Yang; Rachel M Keszycki; Hongxin Dong
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

Review 4.  Alterations in Tau Metabolism in ALS and ALS-FTSD.

Authors:  Michael J Strong; Neil S Donison; Kathryn Volkening
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

Review 5.  The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).

Authors:  Barbara Mroczko; Magdalena Groblewska; Ala Litman-Zawadzka
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

6.  Altered ribosomal function and protein synthesis caused by tau.

Authors:  Harrison Tudor Evans; Deonne Taylor; Andrew Kneynsberg; Liviu-Gabriel Bodea; Jürgen Götz
Journal:  Acta Neuropathol Commun       Date:  2021-06-19       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.